🔎 Trials Near Me

Akèy › Kansè poumon selil ti › Oregon › Portland

Etid klinik pou Kansè poumon selil ti nan Portland, OR

8 etid pou Kansè poumon selil ti ap chèche patisipan nan sit nan ak bò kote Portland (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Ap rekriteFaz 1/2
  • Oregon Health & Science University (OHSU), Portland
Laj 12 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT04585750

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

Ap rekriteFaz 3
  • Oregon Health and Science University /ID# 280071, Portland
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07365241

A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)

Ap rekriteFaz 1/2
  • Providence Portland Medical Center ( Site 1101), Portland
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06780137

A Study of MGC026 in Participants With Advanced Solid Tumors

Ap rekriteFaz 1
  • Providence Cancer Institute, Portland
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT06242470

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

Ap rekriteFaz 3
  • Providence Portland Medical Center, Portland
Laj 18 ak plis · Tout sèks · Mizajou Aug 6, 2026 · NCT06203210

A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

Ap rekriteFaz 1/2
  • Providence Portland Medical Center, Portland
Laj 18 ak plis · Tout sèks · Mizajou Jul 15, 2026 · NCT05652686

Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

Ap rekriteFaz 2
  • Providence Portland Medical Center, Portland
  • Providence Saint Vincent Medical Center, Portland
  • Providence Willamette Falls Medical Center, Oregon City · 12 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Mar 30, 2026 · NCT06769126

A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

Ap rekriteFaz 1
  • Oregon Health & Science University, Portland
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2025 · NCT06805825

Etid Kansè poumon selil ti nan lòt vil

Lòt etid nan Portland

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.